Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing brain stimulation techniques for impulsivity in borderline personality disorder

Official title: Reduction of Impulsivity in Patients With Borderline Personality Disorder Using Dual-site Transcranial Magnetic Stimulation

Run by Hôpital le Vinatier · NCT05942651 · Data updated 2026-11-12

This study is testing a new brain stimulation technique to see if it can help people with borderline personality disorder reduce their impulsivity.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorHôpital le Vinatier
Academic / other
Locations1 site (Bron, AURA)
StatusRecruiting
StartedJanuary 8, 2024
Main results expectedSeptember 20, 2026
Study endsSeptember 20, 2027
Registry record updatedMarch 7, 2024
Trial IDNCT05942651 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with borderline personality disorder as confirmed by a structured psychiatric interview.

Probably not a fit

Patients with other chronic psychiatric conditions or those currently on specific medications that affect GABAergic transmission may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of a non-invasive brain stimulation technique called paired cortico-cortical associative stimulation (ccPAS) in reducing impulsivity among patients diagnosed with borderline personality disorder (BPD). Participants will be randomly assigned to receive either active ccPAS or a sham treatment, with the goal of enhancing connectivity between specific brain regions associated with impulsivity. The study will utilize a double-blind, parallel-group design to ensure unbiased results. By focusing on impulsivity, a key symptom of BPD, the trial seeks to provide insights into potential therapeutic interventions for this challenging condition.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment options for patients with borderline personality disorder, specifically targeting impulsivity.

How similar studies have gone: Other studies utilizing non-invasive brain stimulation techniques have shown promise in treating various psychiatric disorders, suggesting potential for success in this novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of BPD (established by a psychiatrist and confirmed in a structured interview using the MINI) based on the Diagnostic and Statistical Manual of Mental Disorders (DSM V).

Exclusion Criteria:

* Contraindications to TMS/MRI (pacemakers or other devices likely to interfere with the magnetic field).
* Pregnant or breast-feeding women.
* Ongoing anxiolytic treatment (benzodiazepines), neuroleptic treatment or anticonvulsants acting on GABAergic transmission ; 24 hours prior to the protocol.
* Diagnosis of other chronic psychiatric pathology including bipolar disorder type I or II and addictions (except tobacco).
* Protective measure (curatorship or guardianship)

Where it's running

  • Centre Hospitalier Le Vinatier
    Bron, Aura, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.